How is the Cartesian Therapeutics Inc today?

The Cartesian Therapeutics Inc today is trading in the down by -1.37% at 10.06.

What is Cartesian Therapeutics Inc Annual Revenue?

Cartesian Therapeutics Inc Annual Revenue rose 49.64%, in the last year to $38.91 M. Its sector's average revenue growth for the last fiscal year was 8.63%.

What is Cartesian Therapeutics Inc Annual Net Profit?

Cartesian Therapeutics Inc Annual Net Profit rose 64.76% in the last year to $77.42 M. Its sector's average net profit growth for the last fiscal year was -7.19%.

What is Cartesian Therapeutics Inc Price to Earning Ratio?

Cartesian Therapeutics Inc Price to Earning Ratio is -6.82, which is negative.

What is Cartesian Therapeutics Inc Stock Price?

Cartesian Therapeutics Inc Stock Price fell 53.1% and underperformed its sector by 58.14% in the past year.

What is Cartesian Therapeutics Inc Quarterly Revenue?

Cartesian Therapeutics Inc Quarterly Revenue fell 81.16% YoY to $1.1 M. Its sector's average revenue growth YoY for the quarter was 2.8%.

What is Cartesian Therapeutics Inc Quarterly Net profit?

Cartesian Therapeutics Inc Quarterly Net profit rose 68.83% YoY to $17.71 M. Its sector's average net profit growth YoY for the quarter was -210.52%.

What is Cartesian Therapeutics Inc Mutual Fund Holding?

Cartesian Therapeutics Inc Mutual Fund Holding decreased by 0.6% in the last quarter to 18.37.

What is Cartesian Therapeutics Inc Promoter Share Holding?

Cartesian Therapeutics Inc Promoter Share Holding increased by 0.14% in the most recent quarter to 11.28%.

What is Cartesian Therapeutics Inc Institutional Holding?

Cartesian Therapeutics Inc Institutional Holding increased by 0.07% in the last quarter to 25.99.

Cartesian Therapeutics Inc XNAS: RNAC

Cartesian Therapeutics Inc Live Share Price Today, Share Analysis and Chart

Name: Cartesian Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Cartesian Therapeutics Inc
Rating: 0.72725
Author: Trendlyne DVM scores

Download real time

10.06 -0.14 (-1.37%)

75.97% Fall from 52W High

39,754 XNAS Volume

XNAS 14 May, 2025 2:09 PM (EDT)

Not Eligible

Expensive Valuation

6.5 / 100

Technically Bearish

22.6 / 100

1Yr Price target upside is 260%

6 analysts

Cartesian Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Cartesian Therapeutics Inc FAQ

How is Cartesian Therapeutics Inc today?

Cartesian Therapeutics Inc today is trading in the red, and is down by -1.37% at 10.06.

How has Cartesian Therapeutics Inc performed historically?

Cartesian Therapeutics Inc is currently trading down -1.37% on an intraday basis. In the past week the stock fell -4.82%. stock has been down -47.14% in the past quarter and fell -53.10% in the past year. You can view this in the overview section.